XEOU:LSE:LSE-db x-trackers MSCI Europe UCITS (USD)

ETF | Others |

Last Closing

USD 18.72

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.78K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 636.56B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 260.39B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing XEOU:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.21% 91% A- 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.21% 91% A- 83% B
Trailing 12 Months  
Capital Gain 15.78% 82% B 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.78% 80% B- 74% C
Trailing 5 Years  
Capital Gain 75.53% 78% C+ 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 75.53% 76% C+ 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 13.82% 74% C 75% C
Dividend Return 13.82% 74% C 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.57% 62% D 77% C+
Risk Adjusted Return 119.41% 96% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike